Form 4: Walgreens Boots Alliance SVP, Global Controller and CAO, Todd Heckman, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Todd Heckman, SVP, Global Controller and CAO of Walgreens Boots Alliance, reports acquisition and disposition of common stock related to performance share awards and tax obligations.
Summary
- On October 23, 2024, Todd Heckman, SVP, Global Controller and CAO of Walgreens Boots Alliance, acquired 2,120 shares of common stock upon settlement of a performance share award.
- The shares were granted on November 1, 2021, under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan.
- On the same day, Heckman disposed of 621 shares of common stock at a price of $9.35 to satisfy tax withholding obligations.
- Following these transactions, Heckman beneficially owns 43,984 shares of Walgreens Boots Alliance, Inc. common stock, including shares underlying restricted stock units issued in lieu of dividends through October 15, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing primarily reflects routine transactions related to executive compensation and tax obligations. There is no indication of significant positive or negative implications for the company.
Positives
- The acquisition of shares through the performance share award indicates that performance targets were met, which is a positive signal.
Negatives
- The disposal of shares to cover tax obligations, while routine, reduces the overall shareholding.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives. This filing indicates activity related to compensation and tax obligations, which are common occurrences.
Comparison to Industry Standards
- Executive compensation packages often include performance-based equity awards, which are subject to vesting and tax implications.
- The reported transactions are typical for executives receiving and managing equity compensation.
- Similar filings can be observed for executives at comparable companies like CVS Health and Rite Aid, reflecting similar compensation structures and regulatory requirements.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| November 1, 2021 | Date of grant for the performance share award. |
| October 15, 2024 | Date through which restricted stock units were issued in lieu of dividends. |
| October 23, 2024 | Date of the reported transactions (acquisition and disposition of shares). |
| October 25, 2024 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.